Investigator site

Valhalla, New York 10595

0 studies enrolling now · 3 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed
• Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) — Completed